- Home
- CCM vs DYAI Comparison
CCM vs DYAI Comparison
Compare CCM & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- DYAI
- Stock Information
- Founded
- CCM 1997
- DYAI 1979
- Country
- CCM China
- DYAI United States
- Employees
- CCM N/A
- DYAI N/A
- Industry
- CCM Medical/Nursing Services
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCM Health Care
- DYAI Health Care
- Exchange
- CCM Nasdaq
- DYAI Nasdaq
- Market Cap
- CCM 33.3M
- DYAI 28.3M
- IPO Year
- CCM 2009
- DYAI 2004
- Fundamental
- Price
- CCM $6.05
- DYAI $0.98
- Analyst Decision
- CCM
- DYAI Strong Buy
- Analyst Count
- CCM 0
- DYAI 1
- Target Price
- CCM N/A
- DYAI $6.00
- AVG Volume (30 Days)
- CCM 1.9K
- DYAI 62.0K
- Earning Date
- CCM 04-25-2025
- DYAI 08-12-2025
- Dividend Yield
- CCM N/A
- DYAI N/A
- EPS Growth
- CCM N/A
- DYAI N/A
- EPS
- CCM N/A
- DYAI N/A
- Revenue
- CCM $52,603,198.00
- DYAI $3,554,344.00
- Revenue This Year
- CCM N/A
- DYAI $22.56
- Revenue Next Year
- CCM N/A
- DYAI $30.95
- P/E Ratio
- CCM N/A
- DYAI N/A
- Revenue Growth
- CCM N/A
- DYAI 57.59
- 52 Week Low
- CCM $3.80
- DYAI $0.91
- 52 Week High
- CCM $10.50
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- CCM 52.65
- DYAI 49.96
- Support Level
- CCM $5.20
- DYAI $0.91
- Resistance Level
- CCM $5.68
- DYAI $1.02
- Average True Range (ATR)
- CCM 0.17
- DYAI 0.05
- MACD
- CCM 0.06
- DYAI 0.01
- Stochastic Oscillator
- CCM 43.59
- DYAI 46.80
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.